Some ideas to help you in daily practice

Article

Breaking news from Day 4 of ESCRS

New approach to presbyopia treament
This is the first ESCRS congress for 9-month old company, Technolas, which was formed out of a joint venture between Bausch and Lomb's refractive surgery unit and 20/10 Perfect Vision. The new business was founded to innovate in excimer and femtosecond laser technologies, focusing primarily on the correction of presbyopia.

Help for surgeons with higher-resolution micro-endoscopes
Improved visualization of the eye&39;s anatomy is the aim of a new series of high-resolution micro-endoscopes from Endo Optiks.

Mobility is the key to corneal surgery
Ziemer has launched a new corneal surgery model to expand the capabilities of its LDV Femtosecond laser system.

Schwind PresbyMAX treats presbyopia with excimer surgery
Schwind unveiled its PresbyMAX software module at ESCRS, a presbyopia solution for its AMARIS system. According to Schwind, the software makes it possible, for the first time, to treat emmetropic as well as myopic, hyperopic and astigmatic patients whose accommodative response is limited.

More news from the congressBreakthrough micro-lens treatment for presbyopiaAlcon to acquire Swiss biotechnology businessToric IOL enhances refractive outcomes Improving retinal examination speed and efficiency Megatron S4 from Geuder delivers flexibility and mobilityThree steps to better toric surgeryA quartet of solutions for surgeonsAt the sharp endAn all in one optical biometer

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.